APA (7th ed.) Citation

PA, W., A, S., C, P., & I, R. (2015). Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock: Implications of Metabolic Bioactivation. Journal of cardiovascular pharmacology and therapeutics, 20(4), 370. https://doi.org/10.1177/1074248415571456

Chicago Style (17th ed.) Citation

PA, Weeks, Sieg A, Paruthi C, and Rajapreyar I. "Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock: Implications of Metabolic Bioactivation." Journal of Cardiovascular Pharmacology and Therapeutics 20, no. 4 (2015): 370. https://doi.org/10.1177/1074248415571456.

MLA (9th ed.) Citation

PA, Weeks, et al. "Antiplatelet Therapy Considerations in Ischemic Cardiogenic Shock: Implications of Metabolic Bioactivation." Journal of Cardiovascular Pharmacology and Therapeutics, vol. 20, no. 4, 2015, p. 370, https://doi.org/10.1177/1074248415571456.